Not recruitingISRCTN70977225
A pilot study of D-cycloserine-augmented cognitive behavioural therapy (CBT) with exposure therapy in adolescents with OCD (OCD)
Research studyAges 12–18United Kingdom
Understand this study
Who could participate?
This study is for people with OCD. Listed age limits: 12 years to 18 years. Other eligibility criteria apply.
- Listed locations
- United Kingdom
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Institute of Psychiatry, Kings College London (UK)
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- United Kingdom
- Age range
- From 12 Years to 18 Years
- Official registry ID
- ISRCTN70977225
- Official title
Show the full official title
A pilot study of D-cycloserine-augmented cognitive behavioural therapy (CBT) with exposure therapy in adolescents with OCD (OCD)
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Institute of Psychiatry, Kings College London (UK), a university.
Who can participate?
This study is for people with OCD. Listed age limits: 12 years to 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
A comparison to two types of group behaviour therapy for OCD: A pilot randomised controlled trial of behaviour therapy and mindfulness-based behaviour therapy for OCD
A randomised controlled feasibility trial comparing clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of OCD.
